氨酸可以通过改善胆道纤维化和炎症来缓解良性胆道狭窄
Seyeon Joo1, See Young Lee2, Su Yeon Lee2
1Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722; Department of Biomedical Sciences, Yonsei University College of Medicine, Seoul 03722, Korea.
BMB reports
|March 25, 2024
概括
带有支架的氨酸 (TA) 减少了良性胆道狭窄 (BBS) 的纤维化和炎症. 更高剂量的TA在BBS治疗中表现出更快,更强大的抗纤维和抗炎作用.
科学领域:
- 分子生物学分子生物学
- 胃肠病学 胃肠病学
- 生物医学工程 生物医学工程
背景情况:
- 良性胆道狭窄 (BBS) 带来了管理挑战,通常涉及纤维化和炎症.
- 皮质类固醇,如三氨烯酸乙化物 (TA),因其抗纤维化潜力而受到研究.
- 完全覆盖的自扩展金属支架 (FCSEMS) 用于BBS治疗.
研究的目的:
- 为了研究三氨乙胺 (TA) 在BBS中的抗纤维效应的分子机制.
- 评估TA和FCSEMS在管理BBS中的联合疗效.
- 探索类固醇释FCSEMS在BBS治疗中的潜力.
主要方法:
- 免疫组织化学 免疫组织化学
- 艾丽莎·伊丽莎·伊丽莎
- 实时PCR可以实现.
- 对转录组进行分析.
主要成果:
- 在TA中,与纤维化相关的信号的剂量依赖性降低.
- 15毫克TA在4周后表现出效果,30毫克TA在2周内表现出效果.
- 转录组分析显示,纤维细胞中纤维化和炎症通路的下调.
结论:
- 与FCSEMS结合的TA有效地改善了BBS中的纤维化和炎症.
- 分子分析支持类固醇化FCSEMS作为BBS的潜在治疗选择.
- 进一步开发类固醇释的FCSEMS可能会使BBS患者受益.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Chronic Bowel Disorders: Introduction
450
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Drugs for Treatment of Constipation-Predominant IBS
162
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
162
Direct-Acting Cholinergic Agonists: Therapeutic Uses
733
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
733


